YIELD GROWTH Announces it has Completed Formulations and Selected THC strains for 9 Cannabis Products to be Sold in Oregon, USA
Yield Growth Corp. (CSE:BOSS)(OTCQB:BOSQF) (Frankfurt:YG3) is pleased to announce that it has finalized product formulations and selected all THC and CBD strains for its first 9 products to launch in Oregon through a 400 retail distribution network.
Pursuant to its agreement with a licensed cannabis processing facility in Oregon, Yield Growth subsidiary UJ Topicals’ branded products will be launching in the Oregon legal cannabis market. The products include CBD and THC oils, Analgesic Topical Gel with THC and CBD, Pain Balm with THC and CBD, Massage Oil with THC and CBD, and 3 types of capsules containing THC and Ayurvedic herbal formulations, blended with ingredients that have been used to treat arthritis and chronic pain. All of the cannabis topical products have been formulated based on Urban Juve proprietary formulas, for which 11 provisional patents have been filed in the U.S.
“We have formulated our products with very high concentrations of THC and CBD for maximum effect,” says Penny Green, CEO of The Yield Growth Corp. “It’s our hope that Oregon residents will embrace our cannabis products as viable treatments for chronic pain.”
Cannabis treatment is effective for chronic pain and nausea and vomiting due to chemotherapy, according to a 2017 report by the National Academies of Sciences, Engineering and Medicine.
Chronic pain is the most common reason given for medical marijuana prescriptions in the U.S., and chronic pain affects an estimated 100 million Americans, according to an article in healthaffairs.org.
According to Statista, in 2018, legal sales of cannabis amounted to nearly U.S. $10 billion, and sales are projected to be over $16 billion in 2021, of which the State of Oregon is expected to account for almost $1 billion.
About The Yield Growth Corp.
The Yield Growth Corp. is dedicated to the rapid and sustainable growth of cannabis wellness assets. Its directors, officers and advisors have C- level experience at multi-billion dollar international companies including M.A.C Cosmetics and Johnson & Johnson and have worked at Aritzia, Procter & Gamble, Skechers, Pepsi and Coca Cola. Its key assets are 100% owned subsidiaries Urban Juve Provisions Inc., UJ Topicals Inc., UJ Beverages Inc., UJ Edibles Inc. and Thrive Activations Inc. Through its subsidiaries it owns over 60 wellness formulas for topicals and beverages, has registered 29 products with Health Canada, has applied for 11 U.S. provisional patents and is currently selling products online in the U.S. and Canada and through retailers in Canada.
Investor Relations Contacts:
Penny Green, President & CEO
Kristina Pillon, Investor Relations
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Cautionary Statement Regarding Forward-Looking Statements
This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, intellectual property protection, and sale of, and demand for, Urban Juve, UJ Topicals, UJ Beverages and UJ Edibles products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/420fbd0f-8bfa-4049-8843-868897021ec6
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
The product will include polyphenols known to have significant health benefits.